Skip to main content
Premium Trial:

Request an Annual Quote

Got an Idea? Got a Plan?

Premium

Got an Idea? Got a Plan?

VCs for the adventuresome genomics entrepreneur

by Aaron J. Sender

VC Selected Genomic Investments Typical Investment Size Total Capital Website
A.M. Pappas & Associates Aclara, Variagenics, Gene Logic, Incellico, Elitra Pharmaceuticals Up to $6 million $150 million www.ampappas.com
Abingworth 3-Dimensional Pharmaceuticals, Aurora, Devgen, Entelos, Framingham Genomic Medicine, Cobra Therapeutics, GeneMedicine, Hexagen, Iconix, Molecular Dynamics, Pharmacopeia, Quantum Dot, Solexa $4 million as part of a total financing of up to $22 million $225 million www.abingworth.com
Advanced Technology Ventures Ardais, Cepheid, Mosaic Technologies Initial: $2 million to $12 million Total: $15 to $35 million $1.5 billion www.atv-ventures.com
Advent International Array BioPharma, DeCode, Exelixis, Variagenics, Ardais, Galapagos Genomics $3 million to $10 million $4.7 billion www.adventinter-
national.com
Alloy Ventures Applied Biosystems, Lynx, Zyomyx, SurroMed, Molecular Dynamics, Picoliter, Aspira Biosystems Initial: $500,000 to $3 million Total: $10 million $500 million www.alloyventures.com
Alta Partners Aclara, AGY Therapeutics, Cellomics, Cytokinetics, Cytos Biotechnology, DeCode, Genaissance, MitoKor, Xantos Biomedicine Alta California Fund (eary stage): Initial investment of $2 million to $6 million. $6 million to $12 million over the life of the company Alta BioPharma Fund (later stage): $5 million to $10 million over the life of the investment $900 million www.altapartners.com
Ampersand Ventures Aclara $5 million to $15 million $350 million www.ampersandven-
tures.com
Apax Partners Hexagen, Hybrigenics, Compugen, SenseTherapeutics, Lexicon Genetics, Atugen, Syntem, IDgene Initial: $10 million Total: $30 million to $50 million $5.7 billion www.apax.co.uk
Applied Genomic Technology Capital Fund/NewcoGen Group Genomics Collaborative, Anvil Informatics, Nanostream, Hypnion, Cellular Genomics, Beyond Genomics, EngeneOS $1 million to $8 million $215 million www.agtcfunds.com
ARCH Ventures DeCode, First Genetic Trust, Genomica, GenVec, Selective Genetics, Caliper, Illumina Up to $10 million $650 million www.archventure.com
Atlas Venture Artemis Pharmaceuticals, Cellzome, Ciphergen, DeCode, Exelixis, Hexagen, Oxford GlycoSciences, Signature BioScience, Structural GenomiX, Variagenics, DeveloGen, MediGene Initial: $500,000 to $20 million $2.5 billion www.atlasventure.com
Auriga Partners Hybrigenics, Milagen EUR 4 million NA www.aurigapartners.
com
Bay City Capital Akkadix, Epoch Biosciences, InGenuity Systems, Lexicon Genetics, LJL Biosystems, Molecular Applications Group, Syrrx $500,000 to $10 million + more than $450 million www.baycitycapital.
com
Bessemer Venture Partners Millennium, PerSeptive Biosystems, Ardais $100,000 to $10 million $400 million each year www.bvp.com
Boston Millennia Partners Deltagen, DoubleTwist, Proteome Initial: $3 million to $8 million Total: up to $15 million $700 million www.millenniapart-
ners.com
Boston University Community Technology Fund Framingham Genomic Medicine, Myriad, Sequenom Initial: $250,000 to $2 million Total: up to $4 million $55 million www.bu.edu/ctf
Burrill & Co. Cellomics, Aclara, DoubleTwist, GeneFormatics, Orchid BioSciences, Paradigm Genetics, Third Wave, ValiGen, Zyomyx $500,000 to $5 million $250 million www.burrillandco.com
Cardinal Partners Molecular Mining $4 million to $8 million $200 million www.cardinalpartners.
com
CMEA Ventures Aclara, Epicyte, Maxygen, Quantum Dot, Raven Technologies, Syrrx, Tilligen, Perlegen, Genicon $500,000 to $5 million $450 million www.cmeaventures.com
Collinson Howe & Lennox Cellular Genomics, PolyGenomics, Incyte Genomics, Molecular Staging, Genomic Health $250,000 to $5 million $100 million www.chlmedical.com
CW Group Aurora Bioscience, Caliper, Illumina, Millennium, Pharmacopeia, Ribogene, ScriptGen, Sequana, SurfaceLogix $3 million to $5 million $450 million www.cwventures.com
Domain Associates Applied Biosystems, Aurora, DNA Sciences, MitoKor, Molecular Staging, Senomyx, Genquest, PolyGenomics $1 million to $15 million $1 billion www.domainvc.com
Dresdner Kleinwort Capital Genaissance, NetGenics, Oxford GlycoSciences, Physiome, Sequenom EUR 5 million to EUR 10 million EUR 4 billion www.dresdnerkc.com
Emerging Technology Partners Aptus Genomics, Avalon Pharmaceuticals, Clairus Technologies, InforMax, Psychiatric Genomics Initial: $500,000 to $3 million Total: up to $6 million NA www.emrgtech.com
Enterprise Partners Elitra Pharmaceuticals, SurroMed up to $20 million $745 million www.ent.com
Falcon Technology Partners Array BioPharma, Genomica, Ciphergen, DeCode NA NA NA
FBR Technology Venture Partners InforMax, Pluvita $8 million $210 million www.fbrtvp.com
Forward Ventures AGY Therapeutics, Ciphergen, Genicon Sciences, MitoKor, Sequana, Variagenics Initial: $500,000 to $5 million Total: $2.5 million to $10 million $310 million www.forwardventures.
com
GeneChem Management Elitra Pharmaceuticals, Gene Logic, Lexicon Genetics, Reprogen, RGS Genome NA $100 million www.genechem.com
Global Life Science Exelixis, DeveloGen, Sequenom, Artemis Pharmaceuticals, Cytos Biotechnology, Xantos Biomedicine, FRIZ Biochem DM 3 million to DM 5 million DM 130 million www.life-science-ventures.de
Greylock Millennium, Pharmacopeia, Genetics Institute, Molecular Dynamics $1 million to $15 million $1.5 billion www.greylock.com
HealthCap Cytos Biotechnology, Gemini Genomics, Global Genomics, Gyros, Hybrigenics, Orchid BioSciences, PyroSequencing, Syntem, Visual Bioinformatics varies SEK 2.8 billion www.healthcap.se
Industrie Management Holding Biobase, BioPhage, Biopsytec, Hybrigenics EUR 250,000 to EUR 2 million EUR 85 million www.imhventure.de
Institutional Venture Partners DoubleTwist, Iconix NA more than $2 billion www.ivp.com
Intersouth Partners Cogent Neuroscience, Paradigm Genetics, Xanthon Initial: $500,000 to $5 million Total: $10 million $300 million www.intersouth.com
InterWest Partners Elitra Pharmaceuticals, Mycometrix, Xenon Genetics Initial: $1 million to $5 million. Total: $12 million to $15 million $1.6 billion www.interwest.com
Inventages NA EUR 1 million to EUR 4 million EUR 50 million [email protected]
INVESCO Private Capital Genomics Collaborative, LJL Biosystems, Transgenomic, Xenon Genetics $2 million to $20 million $2.6 billion www.privatecapital.
invesco.com
Israel Seed Partners Compugen, IDgene $250,000 to $4 million NA www.israelseed.com
Kleiner Perkins Caufield and Beyers DoubleTwist, Iconix, Millennium, Molecular Dynamics, Nanogen, Oxford Glycosystems, Pharmacopeia, Questcor, Syteni NA NA www.kpcb.com
Life Sciences Partners Sequenom, DevGen, PamGene EUR 500,000 to EUR 5 million EUR 170 million www.lsp.nl
Mayfield Fund Cytokinetics, Discovery Partners, DoubleTwist, Elitra Pharmaceuticals, Millennium $1 million to $10 million $2.23 billion www.mayfield.com
MDS Capital DoubleTwist, Ciphergen, MDS Proteomics, Variagenics $500,000 to $5 million $800 million www.mdscapital.com
Medicis DevGen, Hybrigenics First Round: EUR 250,00 to EUR 1 millionLater Rounds: up to EUR 5 million NA www.medicis.de
Medicus Venture Partners AGY Therapeutics, Molecular Applications Group, Biosite Initial: $35,000 to $3 million Total: up to $5 million NA www.medicusvc.com
Morgenthaler Ventures Protogene, Sequana, Molecular Applications Group $2 million to $10 million $1 billion www.morgenthaler.com
MPM Capital Caliper, Epigenomics, Genesoft, Genzyme Molecular Oncology, GPC Biotech, Macrogenics, Quantum Dot, Syrrx, DoubleTwist $5 million to $50 million $1 billion www.mpmcapital.com
New Enterprise Associates Aurora, Hexagen, Molecular Dynamics, Orchid BioSciences, Sequana $100,000 to $15 million $4.8 billion www.nea.com
NIB Capital (Alpinvest International) Sequenom, DeveloGen, GPC Biotech NA EUR 13.5 billion www.nibcapital.com
OrbiMed Advisors Ciphergen, Structural GenomiX, Bio IT, Molecular Staging, GeneFormatics, LumiCyte, Geneva Proteomics, Caliper $1 million to $20 million $2.75 billion www.orbimed.com
Oxford Bioscience Partners Exelixis, Gene Logic, Genset, Human Genome Sciences, Questcor, Artemis, Cellomics, Exonhit Pharmaceuticals, Genicon, Mosaic Technologies, NetGenics, Orchid BioScience, Physiome, Variagenics, Arradial, Framingham Genomic Medicine, GeneMachines, Psychiatric $1 million to $7 million $400 million www.oxbio.com
Patricof & Co. Ventures Lexicon Genetics, ZymoGenetics $5 million to $100 million NA www.patricof.com
Pequot Private Equity Group Ardais, Compugen, Rosetta Inpharmatics, Spotfire $2 million to $7 million $1.6 billion www.pequotcap.com
Perseus Soros BioPharmaceutical Fund GeneFormatics, Structural Bioinformatics, Valentis $10 million to $20 million $300 million NA
Polaris Venture Partners DeCode Genetics, Paradigm Genetics Initial: $250,000 to $15 million. Total: up to $30 million More than $1 billion www.polarisventures.com
Rendex Partners Devgen, Hybrigenics EUR 1 million to EUR 5 million NA www.rendex.com
Skyline Ventures LJL Biosystems, Nimblegen Systems, Zyomyx Initial: $3 million Total: up to $8 million $100 million www.skylineventures.com
Sprout Group Spotfire, Deltagen, Lynx, Phylos, Sequana, Structural GenomiX, Variagenics, Nanogen $5 million to $50 million $3 billion www.sproutgroup.com
STAR Ventures Sequenom, MediGene $3 million to $10 million $1 billion www.star-ventures.com
Techno Venture Management DeveloGen, GPC Biotech, Ingenium Pharmaceuticals, MediGene, Nanostream, Sequenom, Synomics, Zeptosens, Oxford GlycoSciences, Qiagen Initial: EUR 5 million Total: up to EUR 10 million EUR 600 million www.tvmvc.com
US Venture Partners Applied Biosystems, Compugen, Lynx $4 million to $5 million $2.5 billion www.usvp.com
Venrock Associates Millennium, NetGenics, ScriptGen, Caliper, Illumina, PerSeptive Biosystems, First Genetic Trust, Framingham Genomic Medicine Initial: $2 million to $6 million Total: $5 million to $15 million $1 billion www.venrock.com
Versant Ventures Mycometrix, Syrrx $ 5 million to $7.5 million $272 million www.versantvc.com
Warburg Pincus Oxford GlycoSciences, Arcaris, Visible Genetics, ZymoGenetics $10 million to $100 million $10 billion www.warburgpincus.com